Reuters logo
BRIEF-Oncolys BioPharma signs exclusive license agreement with Jiangsu Hengrui Medicine on OBP-301 in China
November 30, 2016 / 9:20 AM / a year ago

BRIEF-Oncolys BioPharma signs exclusive license agreement with Jiangsu Hengrui Medicine on OBP-301 in China

Nov 30 (Reuters) - Oncolys BioPharma Inc :

* Says co enters into exclusive license agreement with Jiangsu Hengrui Medicine Co Ltd for OBP-301, valid in China mainland, Hong Kong and Macao

* Previous plan was disclosed on May 20

Source text in Japanese: goo.gl/7PYLBq

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below